" We are ambitious, competitive, innovative, dynamic and agile. Our focus is on serving the needs of the medical, pharmaceutical and scientific communities who prescribe, endorse and dispense our products."
Welcome to Avalon Pharma!
When I joined Avalon Pharma 19 years ago, the company was a Saudi Arabian SME with a clear ambition of enhancing the health and wellbeing of the people of Saudi Arabia. The growth and new milestones the company has achieved since that time are a credit to the passion and commitment of each member of our growing family.
We are ambitious, competitive, innovative, dynamic and agile. Our focus is on serving the needs of the medical, pharmaceutical and scientific communities who prescribe, endorse and dispense our products. We create win-win relationships with our commercial partners, (in both the private and public sectors) and we are committed to building long-term partnerships with likeminded healthcare companies in Saudi Arabia and around the world.
Our vision is clear and our commitment to achieving it is second to none. By understanding the needs of our customers and aligning those aspirations to our offering; we will emerge as the Kingdom of Saudi Arabia’s preferred health and beauty company. At the core of this intent is a rigorous quality assurance policy and corporate governance framework.
We are currently revamping our derma range of products and our brand will become the region’s leading Derma brand because of its offering and understanding of the needs of customers across the Middle East and beyond.
We are witnessing exciting and inspiring times of positive change in Saudi Arabia. Avalon Pharma’s strategic plan is aligned with Vision2030 and the National Transformation Program 2020. We plan to make significant investments in local manufacturing, development, technology transfer, logistics, talent development and in the manufacturing of advanced medicines and health and beauty products.
We are intent on expanding our reach; focusing on new export markets and thus allowing Avalon Pharma emerge from its humble beginnings to a pioneering global pharmaceuticals company.
Thank you for your interest and continued support.
Maher L. Ghannam
Chief Executive Officer